formoterol fumarate has been researched along with Lung Diseases, Obstructive in 1 studies
N-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide : A phenylethanoloamine having 4-hydroxy and 3-formamido substituents on the phenyl ring and an N-(4-methoxyphenyl)propan-2-yl substituent.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobsen, JR | 1 |
| Aggen, JB | 1 |
| Church, TJ | 1 |
| Klein, U | 1 |
| Pfeiffer, JW | 1 |
| Pulido-Rios, TM | 1 |
| Thomas, GR | 1 |
| Yu, C | 1 |
| Moran, EJ | 1 |
1 other study available for formoterol fumarate and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Multivalent design of long-acting β(2)-adrenoceptor agonists incorporating biarylamines.
Topics: Adrenergic beta-2 Receptor Agonists; Amines; Animals; Disease Models, Animal; Dose-Response Relation | 2014 |